Arca Biopharma | ABIO - Despesa De Juros Sobre A Dívida

Preço das Ações
59.58
Mudança Diária
-4.02 -6.32%
Mensal
73.15%
Anual
675.78%
Q2 Previsão
57.95




Despesa De Juros Sobre A Dívida Alterar Data
Amgen USD 653M 32M 2025-12
Arca Biopharma USD 504K 246K 2024-09
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 432M 48M 2025-12
Capricor Therapeutics 3.05M 2.46M 2025-12
Cipla INR 140.3M 8.5M 2025-12
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Cytokinetics USD 30.33M 4.01M 2025-12
Daiichi Sankyo JPY 2.16B 1.33B 2025-12
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Laboratory Of America USD 55M 1000K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
Otsuka Holdings JPY 2.21B 866M 2025-12
Pfizer USD 711M 59M 2025-12
United Therapeutics USD 3.1M 100K 2025-12